- Pakistan upholds international climate obligations, with regional governments participating in national goals.
- The government of Pakistan, led by Prime Minister Shehbaz Sharif, is currently preparing a comprehensive climate strategy to meet international obligations.
Pakistan reviews 52 drug pricing proposals for calculation inconsistencies
What happened
Musadik Malik was tasked by Shehbaz Sharif to review 52 drug pricing proposals submitted by the Drug Regulatory Authority of Pakistan. The review found inconsistencies in pricing calculations and reference costs, including the use of inappropriate or insufficiently verified reference prices. The objective of the review was to ensure medicines were priced according to Drap's policy while maintaining the supply of essential medicines.
From geo.tv
Why it matters
The review aims to stabilize the pricing of essential medicines in Pakistan. By correcting discrepancies in maximum retail prices, the government seeks to protect patients from unjustified costs and ensure that pharmaceutical companies can continue supplying necessary drugs.
From geo.tv
Who's involved
- Musadik MalikFederal Minister for Climate Change who led the review of drug pricing proposals
- Shehbaz SharifPrime Minister of Pakistan who tasked Musadik Malik with the review
- PakistanSovereign state where the drug pricing review is taking place
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- health departmentSpeculative
The health department might see its regulatory function stabilized through pricing consistency
- Ministry of FinanceSpeculative
The Ministry of Finance could see its national fiscal planning impacted by stabilized healthcare costs
- Pakistan Institute of Medical SciencesSpeculative
Pakistan Institute of Medical Sciences may see a reduction in operational expenditure due to lower drug costs
Possible ripples
Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.- Drug pricing review may stabilize health department's regulatory functionReview of drug pricing proposals could stabilize the health department's regulatory functionLikely
- Drug price review may influence Muhammad Aurangzeb's economic planningDrug price review may influence Muhammad Aurangzeb's economic planningPossible
- Lower drug prices may reduce operational costs for PIMSLower drug prices could reduce operational costs for Pakistan Institute of Medical SciencesPossible
Keep exploring
The entities involved
-
Musadik Malik
Pakistani politician
-
Shehbaz Sharif
Prime Minister of Pakistan (2022–2023; 2024–present)
-
Pakistan
sovereign state in South Asia
Related events
- Shehbaz Sharif chaired a committee meeting in Khyber Pakhtunkhwa today.
- Shehbaz Sharif defended emergency rule in Khyber Pakhtunkhwa, with Nawaz Sharif backing the measures.
- An economic summit is taking place in Islamabad, Pakistan, involving Prime Minister Shehbaz Sharif.
- The Prime Minister chaired a review meeting in Islamabad today.
- Nawaz Sharif visited Khyber Pakhtunkhwa to review local issues and discuss regional concerns with the Prime Minister.